Literature DB >> 19585271

Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population.

Sang Seop Lee1, Hyun-Ju Jung, Jung Soon Park, In-June Cha, Doo-Yeoun Cho, Jae-Gook Shin.   

Abstract

Cytochrome P450 3A7 (CYP3A7) is expressed in the human fetal liver and plays a role in the metabolism of hormones, drugs, and toxic compounds. Genetic variants of CYP3A7 are associated with serum estrone level, bone density, and hepatic CYP3A activity in adults. We analyzed the genetic variations of CYP3A7 in a Korean population. From direct sequencing of all exons and flanking regions of the CYP3A7 gene in 48 Koreans, we found five genetic variants, including three novel variants. One variant, a thymidine insertion in exon 2 (4011insT), causes premature termination of CYP3A7 translation, which may result in a null phenotype. The novel variant was assigned to the CYP3A7*3 allele by the CYP allele nomenclature committee. For further screen of this novel variant in other ethnic populations, we used pyrosequencing to analyze an additional 185 Koreans, 100 African Americans, 100 Caucasians, and 159 Vietnamese for the presence of this variant. The variant was not found in any other individuals, except for one Korean subject. The frequencies of two known functional alleles, CYP3A7*2 and CYP3A7*1C, were 26 and 0%, respectively, in Koreans. The frequencies of the functional CYP3A7 polymorphisms in Koreans were significantly different from those in Caucasians and African Americans. This is the first report of a null-type allele of the CYP3A7 gene. It also provides population-level genetic data on CYP3A7 in Koreans to reveal the wide ethnic variation in CYP3A7 polymorphism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585271     DOI: 10.1007/s11033-009-9608-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  11 in total

Review 1.  Fetal hepatic drug elimination.

Authors:  J A Ring; H Ghabrial; M S Ching; R A Smallwood; D J Morgan
Journal:  Pharmacol Ther       Date:  1999-12       Impact factor: 12.310

2.  Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.

Authors:  Cristina Rodríguez-Antona; Mary Jande; Anders Rane; Magnus Ingelman-Sundberg
Journal:  Clin Pharmacol Ther       Date:  2005-04       Impact factor: 6.875

3.  CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele.

Authors:  Sarah C Sim; Robert J Edwards; Alan R Boobis; Magnus Ingelman-Sundberg
Journal:  Pharmacogenet Genomics       Date:  2005-09       Impact factor: 2.089

4.  Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene.

Authors:  K Gellner; R Eiselt; E Hustert; H Arnold; I Koch; M Haberl; C J Deglmann; O Burk; D Buntefuss; S Escher; C Bishop; H G Koebe; U Brinkmann; H P Klenk; K Kleine; U A Meyer; L Wojnowski
Journal:  Pharmacogenetics       Date:  2001-03

5.  CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.

Authors:  K Bácsi; J P Kósa; G Borgulya; B Balla; A Lazáry; Z Nagy; C Horváth; G Speer; P Lakatos
Journal:  Calcif Tissue Int       Date:  2007-03-03       Impact factor: 4.333

6.  A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels.

Authors:  Pauline Smit; Ron H N van Schaik; Marloes van der Werf; Annewieke W van den Beld; Jan W Koper; Jan Lindemans; Huibert A P Pols; Albert O Brinkmann; Frank H de Jong; Steven W J Lamberts
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

7.  Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.

Authors:  Ina Koch; Regina Weil; Renzo Wolbold; Jürgen Brockmöller; Elisabeth Hustert; Oliver Burk; Andreas Nuessler; Peter Neuhaus; Michel Eichelbaum; Ulrich Zanger; Leszek Wojnowski
Journal:  Drug Metab Dispos       Date:  2002-10       Impact factor: 3.922

8.  Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.

Authors:  J D Schuetz; S Kauma; P S Guzelian
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.

Authors:  J D Schuetz; D L Beach; P S Guzelian
Journal:  Pharmacogenetics       Date:  1994-02

10.  [Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women].

Authors:  Krisztián Bácsi; János Kósa; Aron Lazáry; Bernadett Balla; Henrik Horváth; István Takács; Zsolt Nagy; Gábor Speer; Péter Lakatos
Journal:  Orv Hetil       Date:  2007-07-08       Impact factor: 0.540

View more
  4 in total

1.  Cold stress in broiler: global gene expression analyses suggest a major role of CYP genes in cold responses.

Authors:  Xingyong Chen; Runshen Jiang; Zhaoyu Geng
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

Review 2.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

3.  Association of IL-10-1082 G/G genotype with lower mortality of acute respiratory distress syndrome in a Chinese population.

Authors:  Xiaodong Jin; Zhi Hu; Yan Kang; Chang Liu; Yongfang Zhou; Xiaodong Wu; Jin Liu; Mingxing Zhong; Chuanxing Luo; Lijing Deng; Yiyun Deng; Xiaoqi Xie; Zhongwei Zhang; Yan Zhou; Xuelian Liao
Journal:  Mol Biol Rep       Date:  2011-10-28       Impact factor: 2.316

4.  Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients.

Authors:  Minji Sohn; Myeong Gyu Kim; Nayoung Han; In-Wha Kim; Jungsoo Gim; Sang-Il Min; Eun Young Song; Yon Su Kim; Hun Soon Jung; Young Kee Shin; Jongwon Ha; Jung Mi Oh
Journal:  Sci Rep       Date:  2018-12-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.